ID21450A - S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon - Google Patents

S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon

Info

Publication number
ID21450A
ID21450A IDP981545A ID981545A ID21450A ID 21450 A ID21450 A ID 21450A ID P981545 A IDP981545 A ID P981545A ID 981545 A ID981545 A ID 981545A ID 21450 A ID21450 A ID 21450A
Authority
ID
Indonesia
Prior art keywords
phenyloksazolidinone
hydrotiopyrane
oxidide
dioxide
dichloromethyl
Prior art date
Application number
IDP981545A
Other languages
English (en)
Indonesian (id)
Inventor
Toni-Jo Poel
Joseph P Martin Jr
Michael R Barbachyn
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ID21450A publication Critical patent/ID21450A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catalysts (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDP981545A 1997-12-05 1998-11-26 S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon ID21450A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6783097P 1997-12-05 1997-12-05
US8949898P 1998-06-16 1998-06-16
US10018598P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
ID21450A true ID21450A (id) 1999-06-10

Family

ID=27371238

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP981545A ID21450A (id) 1997-12-05 1998-11-26 S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon

Country Status (21)

Country Link
US (2) US6083967A (da)
EP (2) EP1036074B1 (da)
JP (1) JP2001525408A (da)
KR (1) KR20010032782A (da)
CN (2) CN1154645C (da)
AT (1) ATE231859T1 (da)
AU (2) AU752454B2 (da)
BR (1) BR9814897A (da)
CA (1) CA2309026A1 (da)
DE (1) DE69811117T2 (da)
DK (1) DK1036074T3 (da)
ES (1) ES2191985T3 (da)
HU (1) HUP0100558A3 (da)
ID (1) ID21450A (da)
NO (1) NO316447B1 (da)
NZ (1) NZ504930A (da)
PL (1) PL340835A1 (da)
SI (1) SI1036074T1 (da)
SK (1) SK7692000A3 (da)
TW (2) TWI239331B (da)
WO (1) WO1999029688A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511468B1 (en) * 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
WO1999064417A2 (en) 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
MY120189A (en) * 1999-11-04 2005-09-30 Upjohn Co Sultam and sultone derived oxazolidinones
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
DE60304360T2 (de) 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
ATE344036T1 (de) 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CA2624310C (en) 2005-10-04 2014-01-07 Bayer Healthcare Ag Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
CN102262066A (zh) * 2011-06-16 2011-11-30 董理 一种检测单胺氧化酶含量的方法和试剂盒
CN104610479B (zh) * 2013-11-05 2017-03-29 中国石油化工股份有限公司 用于乙烯聚合的负载化茂金属催化剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897409A (en) * 1986-09-03 1990-01-30 Delalande S.A. 5-aminoethyloxazolidin-2-one derivatives
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5130316A (en) * 1988-07-29 1992-07-14 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazlidinyl arylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
JP2669579B2 (ja) * 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
EP0610265B1 (en) * 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
WO1994013649A1 (en) * 1992-12-08 1994-06-23 The Upjohn Company Tropone-substituted phenyloxazolidinone antibacterial agents
HUP9901979A3 (en) * 1995-09-01 2000-03-28 Upjohn Co Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings and pharmaceutical compositions containing the same
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
AU2002301031B2 (en) 2005-08-25
CA2309026A1 (en) 1999-06-17
DE69811117T2 (de) 2003-07-17
NZ504930A (en) 2002-05-31
JP2001525408A (ja) 2001-12-11
KR20010032782A (ko) 2001-04-25
DK1036074T3 (da) 2003-06-23
NO20002834L (no) 2000-07-21
SI1036074T1 (en) 2003-08-31
BR9814897A (pt) 2000-10-03
AU752454B2 (en) 2002-09-19
DE69811117D1 (de) 2003-03-06
US6265178B1 (en) 2001-07-24
PL340835A1 (en) 2001-02-26
TWI239331B (en) 2005-09-11
CN1278817A (zh) 2001-01-03
NO316447B1 (no) 2004-01-26
TW200307673A (en) 2003-12-16
CN1532535A (zh) 2004-09-29
HUP0100558A2 (hu) 2002-05-29
HK1032970A1 (en) 2001-08-10
TW553942B (en) 2003-09-21
AU1796899A (en) 1999-06-28
SK7692000A3 (en) 2001-03-12
US6083967A (en) 2000-07-04
EP1036074A1 (en) 2000-09-20
WO1999029688A1 (en) 1999-06-17
ATE231859T1 (de) 2003-02-15
EP1254906A1 (en) 2002-11-06
ES2191985T3 (es) 2003-09-16
NO20002834D0 (no) 2000-06-02
HUP0100558A3 (en) 2002-08-28
EP1036074B1 (en) 2003-01-29
CN1154645C (zh) 2004-06-23

Similar Documents

Publication Publication Date Title
ID21450A (id) S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon
DE69821985D1 (de) Ortho-anthranilamide derivate als antikoagulantien
PT918776E (pt) Sintese total de acilfulvenos antitumorais
TR199901473T2 (xx) Ha�ere �ld�r�c� 1-arilpirazoller
ES2136887T3 (es) Derivados antifungicos de sordaridina.
DE3767778D1 (de) Entzuendung verhindernde und allergie heilende mittel.
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
DE69121259D1 (de) Beta-Lactam-Verbindungen und ihre Herstellung
BR0115996A (pt) Sulfamidotienopirimidinas
DK0841327T3 (da) Triazolantisvampemiddel
DK0623131T3 (da) Alkylderivater af trazodon med CNS-aktivitet
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
DK0812835T3 (da) Optisk aktive thiazolidinonderivater
DE69932269D1 (de) Herstellung optisch aktiver Cyclohexylphenylglykolsäureester
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
BR9902096A (pt) Pitazóis.
FI915025A0 (fi) 8-azabicyklo(3,2,1) oktylalkyltiazolidinoner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DK0963998T3 (da) Azasteroidforbindelse til behandling eller prævention af prostatacancer
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
ATE556075T1 (de) Triazoquinolone-derivate als pestizide
DE3778088D1 (de) Substituierte pyrimidochinoxaline.
TH26544A (th) อนุพันธ์กรด -4 - อัลคิลไทโอ -ไพรมิดิน -5 - อิล อาซีติก